Aemetis (NASDAQ:AMTX) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Aemetis (NASDAQ:AMTXGet Free Report) issued its quarterly earnings results on Tuesday. The specialty chemicals company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.47) by $0.09, Zacks reports. The company had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same period in the previous year, the business posted ($0.59) EPS.

Aemetis Stock Performance

Shares of NASDAQ:AMTX traded down $0.34 during trading hours on Wednesday, hitting $4.28. The stock had a trading volume of 806,190 shares, compared to its average volume of 802,842. The stock’s fifty day simple moving average is $2.70 and its 200 day simple moving average is $3.05. Aemetis has a 1-year low of $2.10 and a 1-year high of $7.03. The firm has a market capitalization of $202.02 million, a price-to-earnings ratio of -3.74 and a beta of 1.23.

Analysts Set New Price Targets

AMTX has been the topic of several research reports. Truist Financial reiterated a “hold” rating and set a $3.50 price objective (down previously from $4.00) on shares of Aemetis in a research note on Wednesday, July 31st. UBS Group dropped their price objective on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research note on Monday, August 19th. HC Wainwright reiterated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research note on Friday, August 2nd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research note on Wednesday, July 31st. Finally, Ascendiant Capital Markets dropped their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $12.95.

View Our Latest Analysis on AMTX

About Aemetis

(Get Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

See Also

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.